ENXTPA:NANOBiotechs
Nanobiotix (ENXTPA:NANO): Assessing Valuation After a 500% Year-to-Date Share Price Surge
Nanobiotix (ENXTPA:NANO) has quietly turned into a high beta oncology name for French investors, with the stock up about 5% over the past month and roughly 144% in the past 3 months.
See our latest analysis for Nanobiotix.
That surge sits on top of a powerful backdrop, with the share price now at $18.28 and a year-to-date share price return near 500%. The 1-year total shareholder return is close to that level, and the 3-year total shareholder return is also strong, which signals that momentum...